Yang S, Zhang X, Gale RP, Du X, et al. Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase. Am J Hematol 2023 May 2. doi: 10.1002/ajh.26943.
PMID: 37128776